A new disorder of lymphocyte apoptosis: Combination of autoimmunity, infectious lymphadenopathy, double negative T cells, and impaired activation-induced cell death

Immunobiology

Volumn 206, Issue 5, 2002, Pages 514-518

  Hundt, Matthias ^a   Posovszky, Carsten ^a   Schmidt, Reinhold E ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; FAS LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; CANALE SMITH SYNDROME; CASE REPORT; CELL DEATH; CLINICAL FEATURE; DIANZANI SYNDROME; DISEASE ASSOCIATION; EXON; FEMALE; GENE MUTATION; HUMAN; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 0036989629     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00199     Document Type: Review

References (11)

1. POSOVSZKY, C., H. FUCHS, C. SCHEUERPFLUG, J. VAN DER WERFF TEN BOSCH, T. BOEHLER, and K. M. DEBATIN. 2001. CD95-death-inducing signaling complex formation in autoimmune lymphoproliferative syndrome/Canale-Smith-Syndrome (ALPS/CSS). Scand. J. Immunol. 54 Suppl 1: Wed 186. (abstr.)
2. CANALE, V. C., and C. H. SMITH. 1967. Chronic lymphadenopathy simulating malignant lymphoma. J. Pediatr. 70: 891.
3. RIEUX-LAUCAT, F., F. DE DEIST, C. HIVROZ, I. A. G. ROBERTS, K. M. DEBATIN, A. FISCHER, and J. P. de VILLARTAY. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347.
4. FISHER, G. H., F. J. ROSENBERG, S. E. STRAUS, J. K. DALE, L. A. MIDDELTON, A. Y. LIN, W. STROBER, M. J. LENARDO, and J. M. PUCK. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935.
5. DIANZANI, U., M. BRAGARDO, D. DIFRANCO, C. ALLIAUDI, P. SCAGNI, D. BUONFIGLIO, V. REDOGLIA, S. BONISSONI, A. CORRERA, I. DIANZANI, and U. RAMENGHI. 1997.Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood 89: 2871.
6. RAMENGHI, U., S. BONISSONI, G. MIGLIARETTI, S. DEFRANCO, F. BOTTAREL, C. GAMBARUTO, D. DIFRANCO, R. PRIORI, F. CONTI, I. DIANZANI, G. VALESINI, F. MERLETTI, and U. DIANZANI. 2000. Deficiency of the Fas apoptosis pathways without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer. Blood 95: 3176.
7. WU, J., J. WILSON, J. HE, L. XIANG, P. H. SCHUR, and J. D. MOUNTZ. 1996. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98: 1107.
8. MÜLLAUER, L., P. GRUBER, D. SEBINGER, J. BUCH, S. WOHLFART, and A. CHOTT, 2001. Mutations in apoptosis genes: a pathogenetic factor for human disease. Mut. Res. 488: 211.
9. JANSSEN, O., R. SANZENBACHER, and D. KABELTTZ. 2000. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res. 301: 85.
10. BUDD, R. C. 2001. Activation-induced cell death. Curr. Opin. Immunol. 13: 356.
11. BOUILLET, P., D. METCALF, D. C. S. HUANG, D. M. TARLINTON, T. W. H. KAY, F. KÖNTGEN, J. M. ADAMS, and A. STRASSER. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis and to preclude autoimmunity. Science 286: 173.